양현 (가톨릭대학교 의과대학)님 | 한빛사연구자 > 한빛사

가톨릭대학교 의과대학

최종업데이트 2022.11.01.

[Letter to the Editor] Reply to: 'A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Need a closer look!'
- J. Hepatol., Jun 2024, 80 (6) S0168-8278(24)00123-5 | https://doi.org/10.1016/j.jhep.2024.02.005
- 2024-06
- 의약학
- 한빛사논문
[Letters to the Editor] Reply to: 'A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Has the correct patient cohort been targeted?'
- J. Hepatol., Oct 2023, 79 (4) S0168-8278(23)00425-7 | https://doi.org/10.1016/j.jhep.2023.06.005
- 2023-10
- 의약학
- 한빛사논문
Reply to: 'A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Considerations'
- J. Hepatol., 2022 Sep 2;S0168-8278(22)03057-4 | https://doi.org/10.1016/j.jhep.2022.08.026
- 2022-09
- 의약학
- 한빛사논문
A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance
- J. Hepatol., Available online 7 April 2022 | https://doi.org/10.1016/j.jhep.2022.03.032
- 2022-04
- 의약학
- 한빛사논문

연구자 ID

저자논문